NEW YORK (GenomeWeb News) – More than 98 percent of Life Technologies' voting shareholders have approved the company's pending $13.6 billion acquisition by Thermo Fisher Scientific, Life Tech announced after the close of the market on Wednesday.

The voting took place at a special shareholders' meeting on Wednesday, and the 98 percent of votes cast in favor of the deal represents more than 72 percent of all outstanding shares, Life Tech said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.